Financhill
Back

Regeneron Pharmaceuticals Stock Price Chart

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
800.47
Seasonality Move:
14.2%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

Regeneron Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 822.36 Sell
20-day SMA: 888.61 Sell
50-day SMA: 1003.71 Sell
200-day SMA: 1008.1 Sell
8-day EMA: 830.33 Sell
20-day EMA: 881.51 Sell
50-day EMA: 965.43 Sell
200-day EMA: 989.48 Sell

Regeneron Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -56.85 Sell
Relative Strength Index (14 RSI): 15.94 Sell
Chaikin Money Flow: -529793 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (836.26 - 990.14) Sell
Bollinger Bands (100): (951.78 - 1157.76) Sell

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Regeneron Pharmaceuticals Stock

Is Regeneron Pharmaceuticals Stock a Buy?

REGN Technical Analysis vs Fundamental Analysis

Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy or a Sell?

Regeneron Pharmaceuticals Stock Info

Market Cap:
88.39B
Price in USD:
804.33
Share Volume:
587.92K

Regeneron Pharmaceuticals 52-Week Range

52-Week High:
1,211.20
52-Week Low:
784.96
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Regeneron Pharmaceuticals Share Price Forecast

Is Regeneron Pharmaceuticals Stock a Buy?

Fundamental Analysis of Regeneron Pharmaceuticals

Is Regeneron Pharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.51 per share.

Technical Analysis of Regeneron Pharmaceuticals

Should I short Regeneron Pharmaceuticals stock?

* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.